Denali Therapeutics (DNLI) EBITDA Margin Growth (1y) (2019 - 2023)
Denali Therapeutics (DNLI) EBITDA Margin Growth (1y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Denali Therapeutics |
4.35 Bn |
4.35 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
4.81 Mn |
| Jun 30, 2023 |
18,051.00 |
| Mar 31, 2023 |
-12,918.00 |
| Dec 31, 2022 |
-31,989.00 |
| Sep 30, 2022 |
-5.43 Mn |
| Jun 30, 2022 |
28,772.00 |
| Mar 31, 2022 |
700.26 Mn |
| Dec 31, 2021 |
-69,444.00 |
| Sep 30, 2021 |
117.38 Mn |
| Jun 30, 2021 |
60,427.00 |
| Mar 31, 2021 |
-689.46 Mn |
| Dec 31, 2020 |
131,347.00 |
| Sep 30, 2020 |
-112.68 Mn |
| Jun 30, 2020 |
5.74 Mn |
| Mar 31, 2020 |
-10.73 Mn |
| Dec 31, 2019 |
-129,859.00 |
| Sep 30, 2019 |
-4.56 Mn |
| Jun 30, 2019 |
-5.50 Mn |
| Mar 31, 2019 |
293,334.00 |
